FRES
Fresh2 Group Ltd
NASDAQ: FRES · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.85
+0.00% today
Updated 2026-04-30
Market cap
$2.97M
P/E ratio
—
P/S ratio
0.12x
EPS (TTM)
$-72.68
Dividend yield
—
52W range
$0 – $0
Volume
0.3M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
3.3
Growth
D5.0
Quality
C+2.5
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Revenue declining -69.90% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2019 | 2020 | 2021 | 2022 | TTM |
|---|---|---|---|---|---|
| Revenue | $10.82M | $19.39M | $17.75M | $12.04M | $16.98M |
| Net income | $-100.79M | $-76.08M | $-117.16M | $-101.89M | $-32.03M |
| EPS | — | — | — | — | $-72.68 |
| Free cash flow | $-51.62M | $-58.10M | $-74.70M | $-56.65M | — |
| Profit margin | -931.86% | -392.39% | -659.93% | -846.01% | — |
Peer comparison
Smart narrative
Fresh2 Group Ltd trades at $0.85. Our Smart Value Score of 33/100 indicates the stock is weak. TTM revenue stands at $16.98M.
Frequently asked questions
What is Fresh2 Group Ltd's stock price?
Fresh2 Group Ltd (FRES) trades at $0.85.
Is Fresh2 Group Ltd overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell).
What is the price target of Fresh2 Group Ltd (FRES)?
The analyst target price is $—, representing NaN% downside from the current price of $0.85.
What is Fresh2 Group Ltd's revenue?
TTM revenue is $16.98M.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.12x
ROE-216.20%
Beta1.28
50D MA$1.49
200D MA$3.06
Shares out0.00B
Float0.14B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—